Table 7.
Country | Year | Number of Patient’s Sera | Toxin-Positive Sera | BoNT Type | References | |||
---|---|---|---|---|---|---|---|---|
A | B | E | ind | |||||
California | 1951–1998 | 122 | 114 | 84% | 12% | 4% | [126] | |
California | 1993–2006 | 37 | 22 | 20 | 2 | [127] | ||
California | 2005–2007 | 73 | 50 | [128] | ||||
Italy | 1986–2015 | 6 | 5 | 5 | [80] | |||
UK | 2000–2004 | 88 | 33 | ~90% | ~10% | [125,129] | ||
Germany | 2005 | 4 | 2 | 2 | [130] | |||
Sweden | 2006 | 1 | 0 | 1 1 | [131] | |||
France | 2008 | 1 | 1 | 1 | [47] | |||
USA | 2011 | 1 | 1 | 1 | [132] | |||
Germany | 2016 | 1 | 1 | 1 | [133] | |||
USA | 2017 | 1 | 1 | 1 2 | [134] | |||
Total | 335 | 230 |
1C. botulinum E detected in the wound by real time PCR, 2 C. subterminale identified in wound culture.